BR112021025676A2 - Composições e métodos para tratar uma afecção mediada por th2 com o uso de prevotella - Google Patents

Composições e métodos para tratar uma afecção mediada por th2 com o uso de prevotella

Info

Publication number
BR112021025676A2
BR112021025676A2 BR112021025676A BR112021025676A BR112021025676A2 BR 112021025676 A2 BR112021025676 A2 BR 112021025676A2 BR 112021025676 A BR112021025676 A BR 112021025676A BR 112021025676 A BR112021025676 A BR 112021025676A BR 112021025676 A2 BR112021025676 A2 BR 112021025676A2
Authority
BR
Brazil
Prior art keywords
compositions
prevotella
methods
mediated condition
treating
Prior art date
Application number
BR112021025676A
Other languages
English (en)
Inventor
Andrea Itano
Holly Ponichtera
Kritika Ramani
A Cormack Taylor
Original Assignee
Evelo Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evelo Biosciences Inc filed Critical Evelo Biosciences Inc
Publication of BR112021025676A2 publication Critical patent/BR112021025676A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material

Abstract

composições e métodos para tratar uma afecção mediada por th2 com o uso de prevotella. a presente invenção refere-se a composições e métodos relacionados a bactérias prevotella que podem ser úteis como agentes terapêuticos, por exemplo, para o tratamento de uma afecção mediada por th2, tal como dermatite atópica e/ou uma alergia alimentar.
BR112021025676A 2019-06-21 2020-06-18 Composições e métodos para tratar uma afecção mediada por th2 com o uso de prevotella BR112021025676A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962864886P 2019-06-21 2019-06-21
US201962910920P 2019-10-04 2019-10-04
PCT/US2020/038335 WO2020257390A1 (en) 2019-06-21 2020-06-18 Compositions and methods of treating a th2-mediated condition using prevotella

Publications (1)

Publication Number Publication Date
BR112021025676A2 true BR112021025676A2 (pt) 2022-05-17

Family

ID=71950833

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021025676A BR112021025676A2 (pt) 2019-06-21 2020-06-18 Composições e métodos para tratar uma afecção mediada por th2 com o uso de prevotella

Country Status (11)

Country Link
EP (1) EP3986431A1 (pt)
JP (1) JP2022536861A (pt)
KR (1) KR20220024684A (pt)
CN (1) CN114245742A (pt)
AU (1) AU2020297498A1 (pt)
BR (1) BR112021025676A2 (pt)
CA (1) CA3143994A1 (pt)
CO (1) CO2022000278A2 (pt)
MX (1) MX2021016034A (pt)
TW (1) TW202120109A (pt)
WO (1) WO2020257390A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202227112A (zh) * 2020-09-21 2022-07-16 美商艾弗洛生物科技股份有限公司 使用棲組織普雷沃菌治療炎症之組成物及方法
TW202227110A (zh) * 2020-09-21 2022-07-16 美商艾弗洛生物科技股份有限公司 用棲組織普雷沃菌調節免疫反應之組成物及方法
JP2024505207A (ja) * 2021-01-26 2024-02-05 エヴェロ バイオサイエンシズ，インコーポレーテッド プレボテラ（Ｐｒｅｖｏｔｅｌｌａ）細胞外小胞調製物
WO2022182707A1 (en) * 2021-02-26 2022-09-01 Evelo Biosciences, Inc. Compositions and methods for reducing cytokine expression
WO2022187064A1 (en) * 2021-03-01 2022-09-09 Evelo Biosciences, Inc. Compositions and methods of treating inflammation using prevotella histicola
CN113509494A (zh) * 2021-09-06 2021-10-19 南京医科大学 普氏菌在制备治疗胆汁淤积性疾病的药物中的应用
CN114028503A (zh) * 2021-12-08 2022-02-11 刘斌 治疗过敏性鼻炎的中西药配方及应用
WO2023146843A1 (en) * 2022-01-25 2023-08-03 Evelo Biosciences, Inc. Extracellular vesicle compositions and methods of use
WO2023200837A1 (en) * 2022-04-13 2023-10-19 Evelo Biosciences, Inc. Compositions and methods of treating inflammation using prevotella histicola
WO2023239728A1 (en) * 2022-06-07 2023-12-14 Evelo Biosciences, Inc. Compositions and methods of treating inflammation using prevotella histicola extracellular vesicles
CN115364223A (zh) * 2022-08-17 2022-11-22 郑州可尔利尔生物科技有限公司 作用于stat 6靶点的物质成分在制备治疗慢性瘙痒症的药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3370748B1 (en) * 2015-11-03 2022-06-08 The Brigham and Women's Hospital, Inc. Therapeutic microbiota for the treatment and/or prevention of food allergy
CN109069558A (zh) * 2016-03-04 2018-12-21 加利福尼亚大学董事会 微生物聚生体及其用途
JP2020533291A (ja) * 2017-09-08 2020-11-19 エヴェロ バイオサイエンシズ，インコーポレーテッド プレボテラ（Ｐｒｅｖｏｔｅｌｌａ）由来の細胞外小胞

Also Published As

Publication number Publication date
KR20220024684A (ko) 2022-03-03
WO2020257390A1 (en) 2020-12-24
EP3986431A1 (en) 2022-04-27
CO2022000278A2 (es) 2022-01-28
CN114245742A (zh) 2022-03-25
AU2020297498A1 (en) 2022-01-20
TW202120109A (zh) 2021-06-01
JP2022536861A (ja) 2022-08-19
MX2021016034A (es) 2022-02-21
CA3143994A1 (en) 2020-12-24

Similar Documents

Publication Publication Date Title
BR112021025676A2 (pt) Composições e métodos para tratar uma afecção mediada por th2 com o uso de prevotella
BR112022002150A2 (pt) Composições e métodos para tratar psoríase e dermatite atópica com o uso de prevotella histicola
MX2020005777A (es) Composicion basada en probioticos y uso de la misma.
BR112018015097A2 (pt) composição e reatores
DOP2017000097A (es) Composiciones y métodos de uso para tratar trastornos metabólicos
AR106768A1 (es) Composiciones que comprenden cepas bacterianas
BR112018069220A2 (pt) uso de polipeptídeo que tem atividade de dnase para tratamento de tecidos
MX2021014709A (es) Composiciones para usarse en el incremento de los niveles de globulos rojos y el tratamiento de enfermedad de celulas falciformes.
CO2017013443A2 (es) Composiciones que comprenden cepas bacterianas del género blautia
AR110684A1 (es) Composiciones que comprenden cepas bacterianas y método de tratamiento
BR112018067689A2 (pt) composições compreendendo cepas bacterianas do gênero blautia para tratar a hipersensibilidade visceral
MX2016009898A (es) Tratamientos para acne resistente.
EP4299129A3 (en) Dosing regimen for treatment of cognitive impairments with blood plasma products
NZ759766A (en) Use of lactic acid bacteria to treat or prevent at least one of postnatal depression and postnatal anxiety
BR112017010808A2 (pt) prevenção e tratamento de infecções microbianas
EA201990257A1 (ru) Фракции плазмы крови в качестве лечения когнитивных расстройств, связанных со старением
BR112019003172A2 (pt) frações de plasma sanguíneo como tratamento para distúrbios cognitivos associados ao envelhecimento
BR112019001039A2 (pt) composição para uso no tratamento de transtorno depressivo maior
BR112018068079A2 (pt) método para cultivar uma planta, agente de ativação para plantas, e composição de agente de ativação de plantas
MX2021002851A (es) Reutilizacion de agente cloroso activado para el tratamiento de carne y aves.
BR112018003780A2 (pt) composições que compreendem um composto de urolitina
PH12016501371A1 (en) Pharmaceutical compositions comprising 15-hepe and methods of treating asthma and lung disorders using same
BR112022002025A2 (pt) Composições e métodos para tratar águas residuais
EA201691452A1 (ru) Композиции для применения в лечении аллергических состояний
MX2019000006A (es) Composiciones para el tratamiento de estrias y ulceras de origen isquemico.

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]